These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

399 related articles for article (PubMed ID: 39221248)

  • 41. Western Diet Triggers NLRP3-Dependent Innate Immune Reprogramming.
    Christ A; Günther P; Lauterbach MAR; Duewell P; Biswas D; Pelka K; Scholz CJ; Oosting M; Haendler K; Baßler K; Klee K; Schulte-Schrepping J; Ulas T; Moorlag SJCFM; Kumar V; Park MH; Joosten LAB; Groh LA; Riksen NP; Espevik T; Schlitzer A; Li Y; Fitzgerald ML; Netea MG; Schultze JL; Latz E
    Cell; 2018 Jan; 172(1-2):162-175.e14. PubMed ID: 29328911
    [TBL] [Abstract][Full Text] [Related]  

  • 42. The role of the interleukin-1 family in trained immunity.
    Moorlag SJCFM; Röring RJ; Joosten LAB; Netea MG
    Immunol Rev; 2018 Jan; 281(1):28-39. PubMed ID: 29248003
    [TBL] [Abstract][Full Text] [Related]  

  • 43. From trained immunity in allergy to trained immunity-based allergen vaccines.
    Martín-Cruz L; Sevilla-Ortega C; Angelina A; Domínguez-Andrés J; Netea MG; Subiza JL; Palomares O
    Clin Exp Allergy; 2023 Feb; 53(2):145-155. PubMed ID: 36494877
    [TBL] [Abstract][Full Text] [Related]  

  • 44. Sepsis-induced immunosuppression: from cellular dysfunctions to immunotherapy.
    Hotchkiss RS; Monneret G; Payen D
    Nat Rev Immunol; 2013 Dec; 13(12):862-74. PubMed ID: 24232462
    [TBL] [Abstract][Full Text] [Related]  

  • 45. Immunotherapy in the context of sepsis-induced immunological dysregulation.
    Wu Y; Wang L; Li Y; Cao Y; Wang M; Deng Z; Kang H
    Front Immunol; 2024; 15():1391395. PubMed ID: 38835773
    [TBL] [Abstract][Full Text] [Related]  

  • 46. Targeting macrophage immunometabolism: Dawn in the darkness of sepsis.
    Kumar V
    Int Immunopharmacol; 2018 May; 58():173-185. PubMed ID: 29625385
    [TBL] [Abstract][Full Text] [Related]  

  • 47. The innate memory response of macrophages to
    Kumar R; Kolloli A; Singh P; Shi L; Kupz A; Subbian S
    Microbiol Spectr; 2024 Aug; 12(8):e0047324. PubMed ID: 38980014
    [TBL] [Abstract][Full Text] [Related]  

  • 48. Monitoring immune dysfunctions in the septic patient: a new skin for the old ceremony.
    Monneret G; Venet F; Pachot A; Lepape A
    Mol Med; 2008; 14(1-2):64-78. PubMed ID: 18026569
    [TBL] [Abstract][Full Text] [Related]  

  • 49. Effect of ethanol exposure on innate immune response in sepsis.
    Roychowdhury S; Pant B; Cross E; Scheraga R; Vachharajani V
    J Leukoc Biol; 2024 May; 115(6):1029-1041. PubMed ID: 38066660
    [TBL] [Abstract][Full Text] [Related]  

  • 50. Targeting Toll-Like Receptors in Sepsis: From Bench to Clinical Trials.
    Chen F; Zou L; Williams B; Chao W
    Antioxid Redox Signal; 2021 Nov; 35(15):1324-1339. PubMed ID: 33588628
    [No Abstract]   [Full Text] [Related]  

  • 51. Potential impact of trained innate immunity on the pathophysiology of metabolic dysfunction-associated fatty liver disease.
    Kountouras J; Kazakos E; Polyzos SA; Papaefthymiou A; Zavos C; Tzitiridou-Chatzopoulou M; Chatzopoulos D; Vardaka E; Gatopoulou A; Kyrailidi F; Mouratidou MC; Doulberis M
    Clin Immunol; 2023 Nov; 256():109776. PubMed ID: 37742792
    [TBL] [Abstract][Full Text] [Related]  

  • 52. Re-recognition of innate immune memory as an integrated multidimensional concept.
    Tang C; Kurata S; Fuse N
    Microbiol Immunol; 2023 Aug; 67(8):355-364. PubMed ID: 37311618
    [TBL] [Abstract][Full Text] [Related]  

  • 53. mTOR- and HIF-1α-mediated aerobic glycolysis as metabolic basis for trained immunity.
    Cheng SC; Quintin J; Cramer RA; Shepardson KM; Saeed S; Kumar V; Giamarellos-Bourboulis EJ; Martens JH; Rao NA; Aghajanirefah A; Manjeri GR; Li Y; Ifrim DC; Arts RJ; van der Veer BM; Deen PM; Logie C; O'Neill LA; Willems P; van de Veerdonk FL; van der Meer JW; Ng A; Joosten LA; Wijmenga C; Stunnenberg HG; Xavier RJ; Netea MG
    Science; 2014 Sep; 345(6204):1250684. PubMed ID: 25258083
    [TBL] [Abstract][Full Text] [Related]  

  • 54. Immunometabolic control of trained immunity.
    Riksen NP; Netea MG
    Mol Aspects Med; 2021 Feb; 77():100897. PubMed ID: 32891423
    [TBL] [Abstract][Full Text] [Related]  

  • 55. Defining trained immunity and its role in health and disease.
    Netea MG; Domínguez-Andrés J; Barreiro LB; Chavakis T; Divangahi M; Fuchs E; Joosten LAB; van der Meer JWM; Mhlanga MM; Mulder WJM; Riksen NP; Schlitzer A; Schultze JL; Stabell Benn C; Sun JC; Xavier RJ; Latz E
    Nat Rev Immunol; 2020 Jun; 20(6):375-388. PubMed ID: 32132681
    [TBL] [Abstract][Full Text] [Related]  

  • 56. Immune Activation in Sepsis.
    Conway-Morris A; Wilson J; Shankar-Hari M
    Crit Care Clin; 2018 Jan; 34(1):29-42. PubMed ID: 29149940
    [TBL] [Abstract][Full Text] [Related]  

  • 57. The role of the gut microbiota in sepsis.
    Haak BW; Wiersinga WJ
    Lancet Gastroenterol Hepatol; 2017 Feb; 2(2):135-143. PubMed ID: 28403983
    [TBL] [Abstract][Full Text] [Related]  

  • 58. Innate (learned) memory.
    Al B; Suen TK; Placek K; Netea MG
    J Allergy Clin Immunol; 2023 Sep; 152(3):551-566. PubMed ID: 37385546
    [TBL] [Abstract][Full Text] [Related]  

  • 59. The changing immune system in sepsis: is individualized immuno-modulatory therapy the answer?
    Boomer JS; Green JM; Hotchkiss RS
    Virulence; 2014 Jan; 5(1):45-56. PubMed ID: 24067565
    [TBL] [Abstract][Full Text] [Related]  

  • 60. Long-term activation of the innate immune system in atherosclerosis.
    Christ A; Bekkering S; Latz E; Riksen NP
    Semin Immunol; 2016 Aug; 28(4):384-93. PubMed ID: 27113267
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 20.